AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Director's Dealing Mar 8, 2018

7581_dirs_2018-03-08_0a7c16d8-403f-4e81-84ef-aebd19960bcc.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0538H

Craneware plc

08 March 2018

Craneware plc

("Craneware", "the Group" or the "Company")

Director's Exercise of Options

8 March 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, yesterday exercised two tranches of options over a total of 29,081 ordinary shares of 1p each ("Ordinary Shares"). The first tranche of 18,248 Ordinary Shares was exercised at a price of 335 pence per Ordinary Share. The second tranche of 10,833 Ordinary Shares was exercised at a price of 400 pence per Ordinary Share.

Following the exercise of these options, Mr Neilson holds 3,377,799 Ordinary Shares in the capital of the Company, representing 12.8% per cent. of the Company's issued share capital.

The exercise of options has been fulfilled via the issue of Ordinary Shares held in the Company's Employee Benefit Trust. There is therefore no change to the Company's issued share capital.

For further information, please contact:

Craneware plc Peel Hunt Alma
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)208 004 4218
Keith Neilson, CEO Dan Webster Caroline Forde
Craig Preston, CFO George Sellar Hilary Buchanan
Nicole McDougall Robyn Fisher

About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

Learn more at www.craneware.com.

Appendix 1

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name: Keith Neilson
2 Reason for the notification
a) Position/Status: Chief Executive Officer
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor
a) Name: Craneware plc
b) LEI: 213800O2CTJ1YFXNXG05
4. Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
a) Description of the financial instrument:

Identification code:
Ordinary Shares

ISIN GB00B2425G68
b) Nature of the transaction: Exercise of Options
c) Price(s) and volume(s): Price(s) Volume(s)
£3.35

£4.00
18,248

10,833
d) Aggregated price(s) and volume(s): Price(s) Volume(s)
£3.592 29,081
e) Date of the Transaction: 7 March 2018
f) Place of the Transaction: Outside of a trading venue

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAADPEESPEEF

Talk to a Data Expert

Have a question? We'll get back to you promptly.